European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologics
Publication date
2021-05
Authors
Thyssen, J P
Vestergaard, C
Barbarot, S
de Bruin-Weller, Marjolein
Bieber, T
Taieb, A
Seneschal, J
Cork, M J
Paul, C
Flohr, C
Editors
Advisors
Supervisors
Document Type
Comment
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Taverne, Infectious Diseases, Dermatology, Letter
Citation
Thyssen, J P, Vestergaard, C, Barbarot, S, de Bruin-Weller, M S, Bieber, T, Taieb, A, Seneschal, J, Cork, M J, Paul, C, Flohr, C, Weidinger, S, Trzeciak, M, Werfel, T, Heratizadeh, A, Darsow, U, Simon, D, Torrelo, A, Chernyshov, P V, Stalder, J-F, Gelmetti, C, Szalai, Z, Svensson, Å, von Kobyletzki, L B, De Raeve, L, Fölster-Holst, R, Christen-Zaech, S, Hijnen, D J, Gieler, U, Gutermuth, J, Bangert, C, Spuls, P I, Kunz, B, Ring, J, Wollenberg, A & Deleuran, M 2021, 'European Task Force on Atopic Dermatitis : position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologics', JEADV : journal of the European Academy of Dermatology and Venereology, vol. 35, no. 5, pp. e308-e311. https://doi.org/10.1111/jdv.17167